KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Payables (2016 - 2025)

Historic Payables for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $5.2 billion.

  • Abbott Laboratories' Payables rose 326.65% to $5.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 billion, marking a year-over-year increase of 326.65%. This contributed to the annual value of $5.2 billion for FY2024, which is 59.05% down from last year.
  • Per Abbott Laboratories' latest filing, its Payables stood at $5.2 billion for Q3 2025, which was up 326.65% from $5.3 billion recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Payables ranged from a high of $5.6 billion in Q1 2022 and a low of $4.8 billion during Q3 2023
  • In the last 5 years, Abbott Laboratories' Payables had a median value of $5.1 billion in 2024 and averaged $5.2 billion.
  • Per our database at Business Quant, Abbott Laboratories' Payables surged by 2595.72% in 2021 and then plummeted by 942.48% in 2023.
  • Quarter analysis of 5 years shows Abbott Laboratories' Payables stood at $5.2 billion in 2021, then grew by 4.87% to $5.5 billion in 2022, then decreased by 4.44% to $5.2 billion in 2023, then decreased by 0.59% to $5.2 billion in 2024, then fell by 1.26% to $5.2 billion in 2025.
  • Its Payables was $5.2 billion in Q3 2025, compared to $5.3 billion in Q2 2025 and $5.2 billion in Q1 2025.